000 | 01428 a2200385 4500 | ||
---|---|---|---|
005 | 20250511211226.0 | ||
264 | 0 | _c19910926 | |
008 | 199109s 0 0 eng d | ||
022 | _a0090-466X | ||
024 | 7 |
_a10.1007/BF03036252 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFrancheteau, P | |
245 | 0 | 0 |
_aMathematical model for in vivo pharmacodynamics integrating fluctuation of the response: application to the prolactin suppressant effect of the dopaminomimetic drug DCN 203-922. _h[electronic resource] |
260 |
_bJournal of pharmacokinetics and biopharmaceutics _cJun 1991 |
||
300 |
_a287-309 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aComputer Simulation |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aErgot Alkaloids _xpharmacokinetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMathematical Computing |
650 | 0 | 4 | _aMethods |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 | _aPharmacokinetics |
650 | 0 | 4 |
_aProlactin _xantagonists & inhibitors |
700 | 1 | _aSteimer, J L | |
700 | 1 | _aDubray, C | |
700 | 1 | _aLavene, D | |
773 | 0 |
_tJournal of pharmacokinetics and biopharmaceutics _gvol. 19 _gno. 3 _gp. 287-309 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF03036252 _zAvailable from publisher's website |
999 |
_c1881483 _d1881483 |